Denmark vs Least Developed Countries (LDCs): Proportion of the target population who received the final dose of
Denmark
81.0%
in 2024
Least Developed Countries (LDCs)
43.0%
in 2024
Denmark rank
22nd
Least Developed Countries (LDCs) rank
20th
Proportion of the target population who received the final dose of over time
- Denmark
- Least Developed Countries (LDCs)
How they compare
Denmark currently reports 81.0% against 43.0% in Least Developed Countries (LDCs), a difference of 38.0%.
That makes Denmark's figure about 1.9 times Least Developed Countries (LDCs)'s.
Across all 14 years both countries report, Denmark has been ahead every year.
Denmark ranks 22nd and Least Developed Countries (LDCs) ranks 20th of 107 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Least Developed Countries (LDCs) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.0% | 2.6% | 53.4% | Denmark |
| 2020s | 80.6% | 21.4% | 59.2% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Denmark or Least Developed Countries (LDCs)?
- Denmark, at 81.0% against 43.0% in Least Developed Countries (LDCs) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Denmark and Least Developed Countries (LDCs)?
- 38.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Least Developed Countries (LDCs)?
- 14 years are reported by both, from 2011 to 2024.
- How do Denmark and Least Developed Countries (LDCs) rank globally for proportion of the target population who received the final dose of?
- Denmark ranks 22nd and Least Developed Countries (LDCs) ranks 20th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.